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Abstract
Background—The subset of patients with essential tremor (ET) that develops Parkinson’s
disease (PD) has not been fully clinically characterized.
Methods—Motor features were retrospectively reviewed in 18 ET patients who developed PD
(ET→PD), 20 ET and 30 PD patients with similar ages and disease durations.
Results—Fewer ET→PD than ET patients had widespread postural and/or action tremor (2/17
[11.8%] vs. 11/17 [64.7%]; p = 0.001) and marginally fewer had cerebellar signs (1/15 [6.7%] vs.
6/18 [33.3%], p = 0.06). ET→PD patients required fewer ET medications than did their
counterparts with ET (p = 0.001). ET→PD patients and PD patients did not differ in UPDRS,
Hoehn and Yahr, or Schwab and England scores (each p≥0.14).
Discussion—ET patients who develop PD may have distinct pre-PD motor features compared to
their counterparts with ET who do not develop co-existing PD. Prospective studies are needed to
evaluate the predictive value of these clinical features for the emergence of PD.
Keywords
Essential tremor; Parkinson’s disease; tremor severity
Copyright: © 2012 Simões et al.
*To whom correspondence should be addressed. rita_moiron_simoes@hotmail.com.
This is an open-access article distributed under the terms of the Creative Commons Attribution–Noncommercial–No Derivatives
License, which permits the user to copy, distribute, and transmit the work provided that the original author(s) and source are credited;
that no commercial use is made of the work; and that the work is not altered or transformed.
Competing Interests: The authors report no conflict of interest.
NIH Public Access
Author Manuscript
Tremor Other Hyperkinet Mov (N Y). Author manuscript; available in PMC 2012 June 20.
Published in final edited form as:
Tremor Other Hyperkinet Mov (N Y). 2012 ; 2: .
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Introduction
Evidence supports an association between Parkinson’s disease (PD) and essential tremor
(ET).1–3 A subset of ET patients might be at higher risk of developing PD;2, 4 however, this
subset has yet to be fully clinically characterized. The aim of these retrospective analyses
was to determine whether patients with both ET and PD (ET→PD) are clinically distinct
from ET patients in terms of certain motor features. Our hypothesis was that ET→PD
patients would have less severe action tremor than ET patients. Also, previous studies2, 5
have suggested that the PD phenotype in ET→PD patients is less severe than that of PD
patients. We compared ET→PD patients with PD patients to explore this issue as well. The
overarching goal of these analyses was to use these clinical data to further refine our
understanding of the subset of ET patients who are at risk of developing PD.
Methods
Patient selection
The clinical database of the Movement Disorder Program of University of Louisville, KY,
was used for the current analyses, which were centered on three patient groups: 1) PD with
previous diagnosis of ET (ET→PD), 2) ET without PD (ET), and 3) PD without ET (PD).
Searching for the words “Parkinson” and “tremor” retrieved 387 and 110 patients,
respectively. Of these, 319 and 64 charts, respectively, were available. These charts were
reviewed by a fourth year neurology resident (R.M.S), with special interest and training in
Movement Disorders, to locate patients with both the diagnosis of PD (meeting UK
Parkinson’s disease Brain Bank criteria6 for probable PD) and a previous history of ET
(fulfilling criteria of definite ET according to the consensus statement of the Movement
Disorder Society,7 if parkinsonian signs were not considered): 18 were identified. Although
no minimum time between ET and PD onset was specified, all but two patients had latencies
≥5 years. Based on the observed age distribution of the 18 ET→PD patients, ET patients
and PD patients were selected if ≥60 years old, in order to ensure age comparability among
groups. Similarly, PD duration in the PD group was restricted to ≤5 years in order to ensure
comparability of PD duration with ET→PD patients.
Seventy-four of the “Parkinson” charts reviewed met the above inclusion criteria for the PD
group (≥60 years old, ≤5 years of PD and UK Parkinson’s disease Brain Bank criteria6 for
probable PD), and the first 30 on an alphabetical list were selected. Of the 64 “tremor”
charts reviewed, 20 fulfilled inclusion criteria for the ET group (age ≥60 years old, definite
ET according to the consensus statement of the Movement Disorder Society7) and all 20
were selected.
Data abstraction
All clinical charts were reviewed (R.M.S.), and every third chart was also reviewed by a
movement disorder neurologist (A.C.) to ensure that abstracted data were valid. To assess
reviewer bias, a third reviewer (E.G., a physician who was a research assistant in the
Movement Disorders division), who was blinded to the study hypothesis, reviewed a random
sample of 10 ET→PD patient charts, assessing the main findings (anatomic distribution of
tremor and number of ET medications). There was high agreement between reviewers,
indicating that reviewer bias was not present. A data abstraction form included self-reported
family history (first-degree relatives) of ET or PD, age at onset (based on first symptom) of
PD and ET, and first parkinsonian symptom, as well as data from the most recent visit. Data
from the most recent visited included age, anatomic distribution of tremor (upper and lower
limb postural and kinetic tremors, head tremor, and voice tremor, based on both history and
examination), ET medications, and data from the neurological examination. Other objective
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data from the most recent visit included cerebellar signs, subscores of the motor Unified
Parkinson’s Disease Rating Scale8 (UPDRS) (rest tremor, rigidity, bradykinesia, postural
instability), total UPDRS score, Hoehn and Yahr score,9 and Schwab and England10 score.
Cerebellar signs were coded as present if any of nystagmus, intention tremor or dysmetria in
the finger-to-nose or heel-to-knee maneuvers were present. Rest tremor, bradykinesia,
rigidity, and postural instability (pull test) were coded as present when the UPDRS score
was ≥1. Widespread postural and/or action tremor indicated that tremor was not restricted to
the arms but also included the head, voice, or legs. To compare ET→PD and PD patients,
the highest UPDRS subscores (right or left side) were used.
Data analyses
Statistical analysis was performed using the SPSS 10 (R.M.S.). Parametric tests were used
throughout (Chi-square test for categorical variables and t-test or ANOVA for continuous
variables). Statistical significance was considered when p<0.05.
Results
Demographics (Table 1)
ET→PD, ET and PD patients had similar gender and age.
ET→PD vs. ET (Table 1)
ET→PD and ET patients had similar duration of ET. Fewer ET→PD patients had
widespread postural and/or action tremor at their most recent visit, especially head tremor.
Marginally fewer ET→ PD had cerebellar signs than did their counterparts with ET.
ET→PD patients required fewer ET medications at their most recent visit than did their
counterparts with ET. Family history of PD was nearly twice as common in ET→PD, but
the difference was not significant. As expected, signs of parkinsonism were more common
in ET→PD than ET patients.
One could argue that, after receiving a diagnosis of PD, ET symptoms and signs in ET→PD
patients might receive less attention (i.e., not commented on in clinical notes and not the
focus of treatment efforts). To assess this possibility, we performed sensitivity analyses.
ET→PD cases were stratified into two groups (mild PD vs. more severe PD) based on the
median UPDRS score. We hypothesized that the presence of fewer ET signs in the group
with more severe PD would support the notion that PD signs were drawing attention away
from ET signs. By contrast, similar severity of ET in the two groups would argue that PD
signs were not drawing attention away from ET signs. We found that a similar proportion of
ET cases in each group had widespread postural and/or action tremor (p = 0.72) and a
similar proportion of ET cases in each group required more than one medication (p = 0.56).
ET→PD vs. PD (Table 1)
The latency between ET and PD onset was 19.3±15.7 (range 2–64) years. The majority
(61.1%, 11/18) had a latency >10 years and, in 11.1% (2/18) it was <5 years. The main PD
phenotypes in the PD group were tremor predominant or mixed tremor–bradykinesia–
rigidity (75.9%; 22/29). Family history of ET was more common in ET→PD than PD
patients. UPDRS scores were similar in the two groups.
Discussion
ET patients are more likely to develop PD than controls11 and there is growing clinical,1, 2, 4
imaging,12–14 and neuropathological15–17 evidence supporting a physiopathological link
between ET and PD.
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In this study, fewer ET→PD patients had widespread postural and/or action tremor or
cerebellar signs and they required fewer ET medications than did their counterparts with ET.
The duration of ET was similar in these ET→PD and ET patients. One possible explanation
is that ET patients who are prone to developing PD have a less severe ET phenotype than do
their counterparts who do not develop PD. An alternative explanation, which we cannot
fully exclude, is that, after receiving a diagnosis of PD, ET symptoms and signs in ET→PD
patients received less attention (i.e., not commented on in clinical notes and not the focus of
treatment efforts). However, our sensitivity analyses suggested that this was not the case.
ET→PD patients have previously been shown to have less severe parkinsonism2, 5 when
compared to other PD patients. This was not noted in the current dataset. This difference
could be due to our small sample size, retrospective design, short duration of PD (less than 5
years), and high proportion of PD patients with non-akinetic rigid phenotypes, which are
known to have a better motor outcome.18, 19
This study has some limitations. First, the retrospective design and the small sample size
may have limited the power to detect associations. It is possible that some group differences
were only detected as trends rather than statistically significant differences. This being said,
many significant associations were detected, indicating that the sample size was adequate for
those comparisons. Second, limb postural, and kinetic tremors, head tremor, and voice
tremor were assessed during routine clinical care; however, a standardized, ordinal tremor
rating scale was not used; this may have biased the results towards the null hypothesis by
reducing precision and obscuring differences between ET groups that may have been
present.
In summary, our study suggests that ET patients who develop PD may have distinct pre-PD
motor features than their counterparts with ET who do not develop co-existing PD.
Prospective studies are now needed to evaluate the predictive value of these clinical features
for the emergence of PD.
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Table 1
Comparison of Demographic Characteristics and Motor Features of ET→PD, ET, and PD Patients
ET → PD (n = 18) ET (n = 20) PD (n = 30) Significance (p)
Demographic characteristics
Age at last visit (mean ± SD years) 74.4 ± 8.2 72.8 ± 8.1 71.0 ± 7.3 0.341
Gender (males: n; %) 13; 72.2% 11; 55.0% 21; 70.0% 0.453
ET → PD vs. ET
Age at onset of ET (mean ± SD years) 49.8 ± 18.6 47.6 ± 24.8 – 0.752
Duration of ET (mean ± SD years) 24.0 ± 15.6 25.4 ± 21.6 – 0.822
Duration of ET prior to PD onset (mean ± SD years) 19.3 ± 15.7 – – –
Family history of ET (n; %) 9/17; 52.9% 11/20; 55.0% – 0.903
Family history of PD (n; %) 3/17; 17.6% 2/20; 10.0% – 0.503
Rest tremor (n; %) 13/16,81.2% 5/19; 26.3% – <0.0013
Bradykinesia (n; %) 11/12,91.7% 3/18; 16.7% – <0.0001
Rigidity (n; %) 11/12,91.7% 5/19; 26.3% – <0.0001
Postural instability (n; %) 4/16; 25.0% 1/17; 5.9% – 0.133
Cerebellar signs (n; %) 1/15,6.7% 6/18, 33.3% – 0.063
Widespread postural and/or action tremor (n; %) 2/17; 11.8% 11/17; 64.7% – 0.0013
 Lower limb tremor (n; %) 1/17; 5.9% 4/17; 23.5% 0.153
 Head tremor (n,%) 1/17; 5.9% 7/17; 41.2% 0.023
 Voice tremor (n, %) 2/17; 11.8% 4/17; 23.5% 0.373
Need > 1 medication for ET at most recent visit (n; %) 2/17; 11.8% 12/18; 66.7% – 0.0013
ET → PD vs. PD
Age at onset of PD (mean ± SD years) 71.4 ± 10.1 – 67.7 ± 7.0 0.142
Duration of PD (mean ± SD years) 4.8 ± 7.6 – 3.8 ± 4.2 0.562
Family History of ET (n, %) 9/17; 52.9% – 2/24; 8.3% <0.00013
Family history of PD (n; %) 5/17; 29.4% – 7/29; 24.1% 0.803
First symptom of PD
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ET → PD (n = 18) ET (n = 20) PD (n = 30) Significance (p)
 Rest tremor (n; %) 8/15; 53.3% – 19/27; 70.4% 0.183
 Bradykinesia (n; %) 7/15; 46.7% – 6/27; 22.2%
 Rigidity (n; %) 0/15; 0% – 2/27; 7.4%
UPDRS – rest tremor upper limb (mean ± SD)2 1.3 ± 1.04 – 1.0 ± 1.04 0.252
UPDRS – finger tapping (mean ± SD)5 1.1 ± 0.74 – 1.5 ± 0.74 0.102
UPDRS – rigidity upper limb (mean ± SD) 1.1 ± 0.54 – 1.4 ± 0.64 0.102
UPDRS – pull test (mean ± SD) 0.5 ± 0.64 – 0.2 ± 0.44 0.252
UPDRS total (mean ± SD) 22.4 ± 14.84 – 30.4 ± 17.64 0.142
Hoehn and Yahr score (mean ± SD) 2.2 ± 0.7 – 2.0 ± 0.4 0.222
Schwab and England score (mean ± SD) 91.8 ± 7.24 – 87.9 ± 8.74 0.152
% are related to the available data;
Statistical tests used:
1ANOVA,
2
t-test, and
3Chi-square.
4
Data not available for all subjects
5
Data from most affected side (right or left) were used.
Abbreviations: ET, essential tremor; PD, Parkinson’s disease; SD, standard deviation; UPDRS, Unified Parkinson’s Disease Rating Scale.
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